3 ms·
In the FDA's press release yesterday [1], they justified Pfizer approval by saying the vaccine had a 91% effectiveness. But everyone knows that number is no lon
by SnowProblem 5y ago
In the FDA's press release yesterday [1], they justified Pfizer approval by saying the vaccine had a 91% effectiveness. But everyone knows that number is no longer true - the data was from March, before Delta. If the FDA were acting responsibly and credibly, they would have used the latest data, but then approval doesn't look so favorable.
It's probably relevant that Pfizer spent over $200M lobbying politicians over the past 20 years, more than any other pharmaceutical [3]. And Biden's administration clearly weren't happy with the FDA - just last week they said they are looking for a new head for November [3]. Interesting how approval came the next week. How much money does Pfizer stand to gain, once mandates and boosters? $15/shot?
[1] https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine https://www.fda.gov/news-events/press-announcements/fda-appr...
[2] https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2762509#ioi200006t1 https://jamanetwork.com/journals/jamainternalmedicine/fullar...
[3] https://www.bloomberg.com/news/articles/2021-08-19/janet-woodcock-ruled-out-for-permanent-fda-commissioner-post https://www.bloomberg.com/news/articles/2021-08-19/janet-woo...
- nradov 5y agoApproval of a vaccine isn't contingent on a specific percentage effectiveness. Less effective drugs are approved all the time as long as the health benefits outweigh the risks and side effects.